Haymarket MediaALK-Rearranged NSCLC Linked to Higher Venous and Arterial Thrombotic Risk
The findings, recently published in the Journal of Thoracic Oncology, suggested that patients with ALK rearrangements may benefit from prophylactic anticoagulation, and venous thromboembolism risk prediction scores may improve if ALK rearrangement status is incorporated.